Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction.
Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction.
复制标题
DOI:
10.1186/1471-2261-13-12
复制
发表时间:
2013-02-28
影响因子:
2.1
通讯作者:
Erlinge D
中科院分区:
文献类型:
--
作者:
Gidlöf O;Smith JG;Miyazu K;Gilje P;Spencer A;Blomquist S;Erlinge D
Increased levels of cardio-enriched microRNAs (miRNAs) have been described in patients with myocardial infarction (MI). We wanted to evaluate the diagnostic and prognostic potential of cardio-enriched miRNAs in patients presenting with a suspected acute coronary syndrome (ACS). Cardio-enriched miRNAs (miR-1, miR-208b and miR-499-5p) were measured using real time PCR in plasma samples from 424 patients with suspected ACS treated in a coronary care unit. miRNAs were assessed for discrimination of a clinical diagnosis of myocardial infarction and for association with 30-day mortality and diagnosis of heart failure. Correlation with left ventricular systolic dysfunction as measured by the ejection fraction (LVEF) was also assessed. To confirm myocardial origin miRNA was measured during coronary artery bypass surgery. miRNAs were higher in MI patients and correlated with LVEF (p < 0.001). Discrimination of MI was accurate for miR-208b (AUC = 0.82) and miR-499-5p (AUC = 0.79) but considerable lower than for Troponin T (AUC = 0.95). Increased miRNA levels were strongly associated with increased risk of mortality or heart failure within 30 days for miR-208b (OR 1.79, 95% CI = 1.38-2.23, p = 1 × 10-5) and miR-499-5p (OR 1.70, 95% CI = 1.31-2.20, p = 5 × 10-5) but the association was lost when adjusting for Troponin T. During surgery miR-208b and miR-499-5p was released in the coronary sinus after cardioplegia-reperfusion to markedly higher levels than in a peripheral vein. Our findings confirm increased levels of cardio-enriched miRNAs in the blood of MI patients and establish association of increased miRNA levels with reduced systolic function after MI and risk of death or heart failure.
登录
查看更多内容
影响因子:
7.5
作者:
Williams AH;Liu N;van Rooij E;Olson EN
通讯作者:
Olson EN
影响因子:
18.2
作者:
Goren, Yaron;Kushnir, Michal;Amir, Offer
通讯作者:
Amir, Offer
影响因子:
9.3
作者:
Adachi, Taichi;Nakanishi, Michio;Iwai, Naoharu
通讯作者:
Iwai, Naoharu
DOI:
10.1007/s00392-011-0343-y
发表时间:
2011-12
期刊:
Clinical research in cardiology : official journal of the German Cardiac Society
影响因子:
--
作者:
Gu YL;Voors AA;Zijlstra F;Hillege HL;Struck J;Masson S;Vago T;Anker SD;van den Heuvel AF;van Veldhuisen DJ;de Smet BJ
通讯作者:
de Smet BJ
影响因子:
5
作者:
Widera, Christian;Gupta, Shashi K.;Thum, Thomas
通讯作者:
Thum, Thomas